Nalaganje...
吉西他滨调整方案治疗晚期非小细胞肺癌的Ⅱ期临床试验
BACKGROUND AND OBJECTIVE: Gemcitabine-platinum-combined with chemotherapy is the most common treatment for advanced non-small cell lung cancer (NSCLC). Gemcitabine is administered once a week in a general three-week schedule. In the present study, gemcitabine is administered on d1 and d5 to improve...
Shranjeno v:
| izdano v: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
中国肺癌杂志编辑部
2012
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5999965/ https://ncbi.nlm.nih.gov/pubmed/22237116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2012.01.01 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|